Our Patroon Creek office has reopened. Use lower lot entrance for all appointments. Albany Medical Center patients should continue to use upper lot entrance to check in for appointments in Suite 210. Radiation, PET and CT patients use radiation entrance in lower lot.Learn More

About Us

CME Credit Available for 8th Annual Translational Oncology Research Symposium

9/17/2014

“Transforming Basic Science into Clinical Practice” is the theme of the 2014 Translational Oncology Research Symposium. This continuing medical education (CME) –certified conference will be held October 16th and 17th at the Hilton Garden Inn at Albany Medical Center.

Hosted by Albany Medical College and New York Oncology Hematology, P.C. (NYOH), the region’s largest provider of cancer care, the 8th annual event is jointly provided by the Medical College of Wisconsin. The 2014 symposium will focus on breast and lung cancers, as well as tumors of unknown primary origin.

Friday morning’s keynote address features Carlos Arteaga, MD, the current president of the American Association for Cancer Research. Thursday evening’s keynote speaker is Vincent Miller, MD of Foundation Medicine, Cambridge, MA.

Vincent Verdile, MD, dean of Albany Medical College and executive vice president for health affairs at Albany Medical Center and Karen Tedesco, MD, Director of the NYOH Hereditary Cancer Risk Assessment Program, will moderate the program.

Attendees can earn AMA PRA Category 1 Credits ™ by participating in this 1.5-day conference.

By bringing together local and national experts in clinical oncology and basic cancer research, the conference aims to raise awareness, build collaboration and foster translational oncology in the Capital and Adirondack regions of New York and beyond.

The symposium is co-chaired by Paul Higgins, PhD, and Paula McKeown-Longo, PhD, co-directors of Albany Med’s Center for Cell Biology and Cancer Research, and Karen Tedesco, MD, director of the NYOH Hereditary Cancer Risk Assessment Program. Dr. Tedesco also serves as the CME course director for this activity.

“Through laboratory based, translational, and clinical research collaboration between NYOH and Albany Medical Center, we continue to offer our patients personalized and innovative cancer treatments which lead to improved outcomes,” said Karen Tedesco, MD, Director of NYOH’s Hereditary Cancer Risk Assessment Program. “Together, we are providing patients with state-of the-art care – close to home.”

The conference includes complimentary meals and snacks, as well as opportunities to view research poster presentations and exhibitor displays. Registration is $25. For more information or to register, visit www.TransOncNY.org.